and specifi city of ASDAS cut-off values for disease activity states

Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis

Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies - The Lancet Rheumatology

Current health resources required for the management of ankylosing spondylitis in developing areas of China

The roles of Single Nucleotide Polymorphism (SNP) Endoplasmic Reticulum Aminopeptidase 1 (ERAP 1) gene in axial spondyloarthritis Indonesian adults - ScienceDirect

Statistical measures of agreement between BASDAI and ASDAS- ESR

Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis – topic of research paper in Clinical medicine. Download scholarly article PDF and read

Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies

Cureus, The Long-Term Effects of Short-Period Adalimumab Biosimilar Usage in Ankylosing Spondylitis

Disease Control Data, Ankylosing Spondylitis

JPM, Free Full-Text

Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study - Fabian Proft, Julia Schally, Henning Christian Brandt, Jan Brandt-Juergens, Gerd